The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 44%. The street (8 analysts) rates it strong buy, with a mean price target of $18. Insiders have been net sellers over the past quarter.
Super Group (SGHC) Limited
SGHC · the NYSE · USD · Market cap $5.9B · 2,726 employees
Super Group (SGHC) Limited operates as an online sports betting and gaming operator.
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago
Screened 2026-11-13 · the tape above runs as of 04:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price11.64 USD at the 13 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 13 Nov 2026
- Our regime readAccumulation, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans slightly to calls (put/call 0.75)
- Last reviewed13 Nov 2026 (4 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $11.70 to $18.87, base estimate $16.41 (screen dated 2026-11-13).
- Trend Accumulation
- Insiders insiders sold, $29,256, latest filing 2026-11-02
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.75, read 2026-11-13
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its accumulation label.
Super Group (SGHC) Limited holds its Accumulation at $11.64. Elevated stress, defensive posture warranted, held for 80 days.
| Phase | Accumulation |
| Quantitative state | Elevated stress, defensive posture warranted, held for 80 days |
| Price at the screen | $11.64 |
| Valuation | 14.41 trailing · 12.87 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 1.10 |
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: gambling
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Prohibited keyword in sector/industry: gambling | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Super Group (SGHC) does not clear the screen at the business-activity stage. It operates in gambling, so the financial ratios are not the deciding factor here.
Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when SGHC's ethical verdict changes
Today SGHC does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 13 Nov 2026: it trades at roughly a 29% discount to our $16.41 fair value, 9.70% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. A 29.1% discount to the base estimate.
Third-party analyst targets: 9 covering, consensus Strong Buy. The average target sits +55% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $16.41, with a range of $11.70 to $18.87, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsBetting apps clear numbers but fail ethics
Every weekend millions place small wagers on phones and the cash moves through online betting platforms that sit outside normal financial rails. Super Group runs two such brands and shows revenue rising 18 percent, an 11 percent profit margin and 36 percent return on equity, all at a forward multiple of 16.5 times with analysts pointing to further upside.
We pass without hesitation. The business clears conventional value screens yet trips the ethical test on gambling, which removes it from consideration regardless of the 31 percent gap between price and modelled worth.
High returns often mask the sector's regulatory and social risks that can shift quickly with new rules or public backlash. The opportunity rating stays at none for this reason.
Analysis, not advice.
| Forward P/E | 12.9xpriced for continued growth |
| Trailing P/E | 14.4xreasonably valued |
| EPS, trailing | 0.81 |
| EPS, forward | 0.91 |
| Revenue growth | +9.7%steady growth |
| Profit margin | 16.6%healthy profit margins |
| Return on equity | 49.2%an exceptional return on shareholder capital |
| Dividend yield | 1.33% |
| Debt to equity | 0.08minimal debt: a conservative balance sheet |
| Current ratio | 2.35comfortably covers its short-term bills |
| Beta | 1.10moves a little more than the market |
| Short interest, float | 0.19% |
| 52-week range | 8.46 - 15.86 |
| Market cap | $5.9B |
| Employees | 2,726 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: its business and earnings are exposed to Guernsey and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeSGHC trades on the NYSE (the company is based in Guernsey). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 6.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 44%. The street (8 analysts) rates it strong buy, with a mean price target of $18. Insiders have been net sellers over the past quarter.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 44%. The street (8 analysts) rates it strong buy, with a mean price target of $18. Insiders have been net sellers over the past quarter.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 44%. The street (8 analysts) rates it strong buy, with a mean price target of $18. Insiders have been net sellers over the past quarter.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 44%. The street (8 analysts) rates it strong buy, with a mean price target of $18. Insiders have been net sellers over the past quarter.
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 15.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 44%. The street (8 analysts) rates it strong buy, with a mean price target of $18. Insiders have been net sellers over the past quarter.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 44%. The street (8 analysts) rates it strong buy, with a mean price target of $18.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 44%. The street (8 analysts) rates it strong buy, with a mean price target of $18.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 44%. The street (8 analysts) rates it strong buy, with a mean price target of $18.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Here is What to Know Beyond Why Super Group (SGHC) Limited (SGHC) is a Trending Stock Yahoo Finance · 5d ago
- 3 Reasons Why Growth Investors Shouldn't Overlook Super Group (SGHC) (SGHC) Yahoo Finance · 8d ago
- Super Group (SGHC) (SGHC) Upgraded to Strong Buy: Here's Why Yahoo Finance · 11d ago
- Does Super Group (SGHC) (SGHC) Have the Potential to Rally 58.56% as Wall Street Analysts Expect? Yahoo Finance · 11d ago
- Super Group to Participate in Upcoming Investor Conferences Yahoo Finance · 12d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-02 | Ross Kirsty Farrah | COO | S - Sale+OE | 2,724 | $29,256 |
| 2026-09-14 | Ben David Alon | CTO | S - Sale | 23,300 | $321,307 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $13.18 | +4.1% | · | $1,041 | +4.1% |
| 2 months | $10.23 | +34.1% | · | $1,341 | +34.1% |
| 3 months | $10.83 | +26.7% | $0.05 | $1,272 | +27.2% |
| 6 months | $11.47 | +19.7% | $0.05 | $1,201 | +20.1% |
| 1 year | $9.22 | +48.8% | $0.09 | $1,498 | +49.8% |
| 2 years | $3.20 | +328.8% | $0.38 | $4,407 | +340.7% |
| 3 years | $3.21 | +327.6% | $0.38 | $4,394 | +339.4% |
| 5 years | $9.57 | +43.4% | $0.38 | $1,473 | +47.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever SGHC does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.